What is Insmed Inc (INSM)?
Insmed Inc is a biopharmaceutical company focused on developing therapies for rare and serious diseases. The company specializes in inhaled and systemic treatments for conditions such as pulmonary infections and genetic disorders. Insmed's product development includes therapies designed to improve patient outcomes in diseases with limited treatment options. The company conducts clinical research and regulatory activities to advance its pipeline. Insmed collaborates with healthcare professionals and patient communities to support disease awareness and treatment access. Its operations encompass drug discovery, development, manufacturing, and commercialization within the rare disease therapeutic area. Insmed operates under regulatory frameworks applicable to pharmaceutical companies engaged in specialty medicine.
Insmed Inc Stock Price Today: Live Overview
The price today is shaped by intraday movements, with Insmed Inc currently at $143.69. The session's price range lies between $143.77 and $149.3, accompanied by a daily change of +6.4625%.
FAQ: Insmed Inc (INSM)
What is the current price of INSM stock?
Insmed Inc is currently priced at $143.69.
Does INSM pay dividends?
Insmed Inc does not pay dividends.
Does INSM have a formal corporate presence or regional headquarters in the UAE?
Insmed Inc operates in the UAE through partners and distributors without a direct presence.
What is INSM best known for?
The company is most famous for its therapies targeting rare lung diseases.
What assets are typically shown together with INSM?
Commonly shown alongside INSM: Thermo Fisher, Invesco MSCI USA Universal Screened UCITS ETF, Shimao Property
Latest shares articles



